Scott A. Wildman

3.4k total citations · 1 hit paper
39 papers, 2.2k citations indexed

About

Scott A. Wildman is a scholar working on Molecular Biology, Computational Theory and Mathematics and Pharmacology. According to data from OpenAlex, Scott A. Wildman has authored 39 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 13 papers in Computational Theory and Mathematics and 6 papers in Pharmacology. Recurrent topics in Scott A. Wildman's work include Computational Drug Discovery Methods (13 papers), Protein Structure and Dynamics (5 papers) and Liver physiology and pathology (4 papers). Scott A. Wildman is often cited by papers focused on Computational Drug Discovery Methods (13 papers), Protein Structure and Dynamics (5 papers) and Liver physiology and pathology (4 papers). Scott A. Wildman collaborates with scholars based in United States, United Kingdom and China. Scott A. Wildman's co-authors include Gordon M. Crippen, James W. Janetka, Zhenfu Han, F. Michael Hoffmann, P. A. Christiansen, Jonathan Duckett, Gino A. DiLabio, Claire M. Peppiatt‐Wildman, Aswini Balachandran and Corinne K. Cusumano and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and The Journal of Chemical Physics.

In The Last Decade

Scott A. Wildman

39 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prediction of Physicochemical Parameters by Atomic Contributions

1999 1.1k citations Scott A. Wildman, Gordon M. Crippen Journal of Chemical Information and Computer Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Scott A. Wildman United States	21	1.0k	762	474	325	241	39	2.2k
Hongming Chen China	28	1.2k 1.2×	419 0.5×	325 0.7×	524 1.6×	183 0.8×	93	2.7k
Gregory A. Ross United States	17	1.2k 1.1×	507 0.7×	290 0.6×	294 0.9×	93 0.4×	26	2.0k
Art E. Cho South Korea	20	1.4k 1.3×	528 0.7×	530 1.1×	306 0.9×	86 0.4×	67	2.6k
Martin Smieško Switzerland	27	1.0k 1.0×	560 0.7×	445 0.9×	134 0.4×	124 0.5×	102	2.1k
Francesca Spyrakis Italy	30	1.7k 1.7×	646 0.8×	306 0.6×	410 1.3×	243 1.0×	113	2.9k
Qi-Shi Du China	27	1.7k 1.6×	634 0.8×	289 0.6×	347 1.1×	343 1.4×	74	2.7k
Paul Labute Canada	20	1.7k 1.7×	922 1.2×	485 1.0×	368 1.1×	78 0.3×	42	2.9k
Joseph W. Kaus United States	8	1.6k 1.6×	745 1.0×	586 1.2×	348 1.1×	103 0.4×	8	2.7k
Dmitry Lupyan United States	12	1.9k 1.9×	723 0.9×	569 1.2×	403 1.2×	108 0.4×	14	3.0k
Zoe Cournia Greece	28	2.1k 2.0×	968 1.3×	460 1.0×	510 1.6×	101 0.4×	65	3.2k

Countries citing papers authored by Scott A. Wildman

Since Specialization

Citations

This map shows the geographic impact of Scott A. Wildman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott A. Wildman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott A. Wildman more than expected).

Fields of papers citing papers by Scott A. Wildman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott A. Wildman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott A. Wildman. The network helps show where Scott A. Wildman may publish in the future.

Co-authorship network of co-authors of Scott A. Wildman

This figure shows the co-authorship network connecting the top 25 collaborators of Scott A. Wildman. A scholar is included among the top collaborators of Scott A. Wildman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott A. Wildman. Scott A. Wildman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hunt, Jack F.V., Meng Li, Ryan D. Risgaard, et al.. (2021). High Throughput Small Molecule Screen for Reactivation of FMR1 in Fragile X Syndrome Human Neural Cells. Cells. 11(1). 69–69. 4 indexed citations

Zhang, Huikun, Spencer S. Ericksen, Ching-pei Lee, et al.. (2019). Predicting kinase inhibitors using bioactivity matrix derived informer sets. PLoS Computational Biology. 15(8). e1006813–e1006813. 7 indexed citations

Tyagi, Rahul, Mostafa A. Elfawal, Scott A. Wildman, et al.. (2019). Identification of small molecule enzyme inhibitors as broad-spectrum anthelmintics. Scientific Reports. 9(1). 9085–9085. 22 indexed citations

Zhou, Ting, Qiwei Wang, Noel Phan, et al.. (2019). Identification of a novel class of RIP1/RIP3 dual inhibitors that impede cell death and inflammation in mouse abdominal aortic aneurysm models. Cell Death and Disease. 10(3). 226–226. 71 indexed citations

Zhao, Changgui, Zhi‐Xiong Ma, Scott A. Wildman, et al.. (2019). A general strategy for diversifying complex natural products to polycyclic scaffolds with medium-sized rings. Nature Communications. 10(1). 4015–4015. 82 indexed citations

Singh, Megh, Leslie A. Weiss, Rachel L. Kinsella, et al.. (2019). Identification of 4-Amino-Thieno[2,3- d ]Pyrimidines as QcrB Inhibitors in Mycobacterium tuberculosis. mSphere. 4(5). 27 indexed citations

Balachandran, Aswini, et al.. (2018). Age, menopausal status and the bladder microbiome. European Journal of Obstetrics & Gynecology and Reproductive Biology. 228. 126–129. 47 indexed citations

Kapoor, Vaishali, David Dadey, Kim Phi Phụng Nguyễn, et al.. (2016). Tumor-Specific Binding of Radiolabeled PEGylated GIRLRG Peptide: A Novel Agent for Targeting Cancers. Journal of Nuclear Medicine. 57(12). 1991–1997. 22 indexed citations

Wang, Qi, Esley M. Heizer, Bruce A. Rosa, et al.. (2016). Characterization of parasite-specific indels and their proposed relevance for selective anthelminthic drug targeting. Infection Genetics and Evolution. 39. 201–211. 7 indexed citations

10.

Jones, Darin E., et al.. (2015). Structure-based discovery of small molecule hepsin and HGFA protease inhibitors: Evaluation of potency and selectivity derived from distinct binding pockets. Bioorganic & Medicinal Chemistry. 23(10). 2328–2343. 24 indexed citations

11.

Simpson, Catherine, Nathaniel G. Jones, Emily A. Hull-Ryde, et al.. (2015). Identification of Small Molecule Inhibitors That Block the Toxoplasma gondii Rhoptry Kinase ROP18. ACS Infectious Diseases. 2(3). 194–206. 9 indexed citations

12.

Hresko, Richard C., Thomas E. Kraft, Anatoly Tzekov, Scott A. Wildman, & Paul W. Hruz. (2014). Isoform-selective Inhibition of Facilitative Glucose Transporters. Journal of Biological Chemistry. 289(23). 16100–16113. 16 indexed citations

13.

Wildman, Scott A.. (2013). Approaches to Virtual Screening and Screening Library Selection. Current Pharmaceutical Design. 19(26). 4787–4796. 7 indexed citations

14.

Lourido, Sebastian, Chao Zhang, Michael S. Lopez, et al.. (2013). Optimizing Small Molecule Inhibitors of Calcium-Dependent Protein Kinase 1 to Prevent Infection by Toxoplasma gondii. Journal of Medicinal Chemistry. 56(7). 3068–3077. 52 indexed citations

15.

Wildman, Scott A., et al.. (2013). The Natural Product Dihydrotanshinone I Provides a Prototype for Uncharged Inhibitors That Bind Specifically to the Acetylcholinesterase Peripheral Site with Nanomolar Affinity. Biochemistry. 52(42). 7486–7499. 10 indexed citations

16.

Wildman, Scott A., et al.. (2011). Drug‐like Leads for Steric Discrimination between Substrate and Inhibitors of Human Acetylcholinesterase. Chemical Biology & Drug Design. 78(4). 495–504. 22 indexed citations

17.

Wildman, Scott A. & Gordon M. Crippen. (2003). Validation of DAPPER for 3D QSAR: Conformational Search and Chirality Metric. Journal of Chemical Information and Computer Sciences. 43(2). 629–636. 11 indexed citations

18.

Wildman, Scott A. & Gordon M. Crippen. (2002). Three-dimensional molecular descriptors and a novel QSAR method. Journal of Molecular Graphics and Modelling. 21(3). 161–170. 18 indexed citations

19.

Wildman, Scott A. & Gordon M. Crippen. (1999). Prediction of Physicochemical Parameters by Atomic Contributions. Journal of Chemical Information and Computer Sciences. 39(5). 868–873. 1072 indexed citations breakdown →

20.

Wildman, Scott A., Gino A. DiLabio, & P. A. Christiansen. (1997). Accurate relativistic effective potentials for the sixth-row main group elements. The Journal of Chemical Physics. 107(23). 9975–9979. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact